Literature DB >> 17220000

Metaplasia of chondrocytes into osteoblasts.

Krzysztof H Włodarski1, Paweł K Włodarski, Aniela Brodzikowska.   

Abstract

Hypertrophic chondrocytes, commonly considered as terminal cells responsible for apoptotic elimination in endochondral osteogenesis, have the potential to switch their metabolic role and enter osteoblastic differentiation, based on histochemical, immunohistochemical, biochemical and cytological analysis. During endochondral osteogenesis, some osteocytes are derived from hypertrophic chondrocytes. Also non-hypertrophic chondrocytes are able to transform into osteogenic cells, and the bone thus formed is termed "transchondroid bone". In this review a summary and discussion of reports on chondrocyte transdifferentiation is given.

Entities:  

Mesh:

Year:  2006        PMID: 17220000     DOI: 10.3409/173491606778557491

Source DB:  PubMed          Journal:  Folia Biol (Krakow)        ISSN: 0015-5497            Impact factor:   0.432


  4 in total

Review 1.  Signaling pathways regulating cartilage growth plate formation and activity.

Authors:  William E Samsa; Xin Zhou; Guang Zhou
Journal:  Semin Cell Dev Biol       Date:  2016-07-11       Impact factor: 7.727

2.  Generation and characterization of Col10a1-mcherry reporter mice.

Authors:  Peter Maye; Yu Fu; David L Butler; Kumar Chokalingam; Yaling Liu; Jane Floret; Mary Louise Stover; Richard Wenstrup; Xi Jiang; Cindi Gooch; David Rowe
Journal:  Genesis       Date:  2011-05       Impact factor: 2.487

3.  Morphological and molecular characterization of developing vertebral fusions using a teleost model.

Authors:  Elisabeth Ytteborg; Jacob Torgersen; Grete Baeverfjord; Harald Takle
Journal:  BMC Physiol       Date:  2010-07-06

4.  Hypertrophic chondrocytes in the rabbit growth plate can proliferate and differentiate into osteogenic cells when capillary invasion is interposed by a membrane filter.

Authors:  Tetsuya Enishi; Kiminori Yukata; Mitsuhiko Takahashi; Ryosuke Sato; Koichi Sairyo; Natsuo Yasui
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.